Clin2
NCT06809166Possibly a fitRecruiting

Contrave for weight loss in adults with obesity

ObesityWeight LossWeight ManagementDietary InterventionObesity/Therapy

Part of Hormones & metabolism clinical trials.

This study tests whether a weight loss medication called Contrave can help adults with obesity lose weight by changing how their body uses energy and handles food. If you qualify, you will take Contrave and be monitored for several months.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
40 people
Ages
18 years to 64 years
Study type
Interventional

Who can take part

  • You are 18 to 64 years old.
  • Your body mass index (BMI) is over 30.
  • You are being seen at a specialized weight loss clinic (the LEAF clinic) or have been referred by your doctor.
  • You are not currently taking antidepressants, thyroid medication, or any other medicine that could affect appetite.
  • You do not have diabetes, uncontrolled high blood pressure, or a history of heart problems.
  • You do not have a personal or family history of seizures, an eating disorder, or a major psychiatric condition like bipolar disorder or psychosis.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06143956Recruiting· Phase 2
Weight loss treatments for adults with obesity

This clinical trial tests new treatments for adults who are overweight or have obesity. The goal is to help people lose weight and improve their health.

Chandler, Arizona
NCT07332273Recruiting· Phase 3
Levothyroxine for weight loss in obesity

This trial tests whether adding levothyroxine (a thyroid hormone) to a low-calorie diet helps people with obesity lose more weight. It is for adults aged 25-60 with a BMI of 30-39.9 who have either mild underactive thyroid or normal thyroid but higher thyroid hormone levels in the normal range.

Cadiz
NCT07467447Recruiting· Phase 2
Testing a weight-loss drug for people with obesity or overweight

This trial tests whether an experimental drug (LY3437943) can help people with obesity or overweight lose weight. It compares the drug to a placebo (inactive shot), and you must be willing to give yourself daily injections.

Shenzhen, Guangdong
NCT07752979Recruiting· Phase 2
New drug for weight loss in adults with obesity or overweight

This study tests an investigational drug called ABBV-295 to see if it helps adults with obesity or overweight who have weight-related health conditions lose weight. It may offer a new treatment option for managing weight and improving overall health.

Pelham, Alabama
NCT07628127Recruiting· Phase 1
Weight loss pill study for adults with excess weight

This study tests an experimental pill that may help people with overweight or obesity lose weight. It compares the pill alone or with another medication to see if it is safe and works well.

Brisbane
NCT06174389Recruiting
Weight loss study: diet, appetite and body changes

This study looks at how diet, appetite, and body changes work together during weight loss. It's designed for people with a BMI of 30 to 50 who want to lose weight and are not taking certain medications or have certain health conditions.

Seattle, Washington

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.